Overview of Reviews

You have free access to this content

Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews

  1. Philip J Wiffen1,
  2. Sheena Derry1,*,
  3. R Andrew Moore1,
  4. Dominic Aldington2,
  5. Peter Cole3,
  6. Andrew S C Rice4,
  7. Michael PT Lunn5,
  8. Katri Hamunen6,
  9. Maija Haanpaa7,
  10. Eija A Kalso6,8

Editorial Group: Cochrane Pain, Palliative and Supportive Care Group

Published Online: 11 NOV 2013

Assessed as up-to-date: 23 AUG 2013

DOI: 10.1002/14651858.CD010567.pub2

How to Cite

Wiffen PJ, Derry S, Moore RA, Aldington D, Cole P, Rice ASC, Lunn MPT, Hamunen K, Haanpaa M, Kalso EA. Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews. Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD010567. DOI: 10.1002/14651858.CD010567.pub2.

Author Information

  1. 1

    University of Oxford, Pain Research and Nuffield Department of Clinical Neurosciences, Oxford, Oxfordshire, UK

  2. 2

    Royal Hampshire County Hospital, Winchester, UK

  3. 3

    Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford Pain Relief Unit, Oxford, UK

  4. 4

    Imperial College London, Pain Research, Department of Surgery and Cancer, Faculty of Medicine, London, UK

  5. 5

    National Hospital for Neurology and Neurosurgery, Department of Neurology and MRC Centre for Neuromuscular Diseases, London, UK

  6. 6

    Helsinki University Central Hospital, Department of Anaesthesia, Intensive Care Medicine, Emergency Medicine and Pain Medicine, Helsinki, Finland

  7. 7

    Helsinki University Central Hospital, Pain Clinic and Department of Neurosurgery, Helsinki, Finland

  8. 8

    University of Helsinki, Institute of Clinical Medicine, Helsinki, Finland

*Sheena Derry, Pain Research and Nuffield Department of Clinical Neurosciences, University of Oxford, Pain Research Unit, Churchill Hospital, Oxford, Oxfordshire, OX3 7LE, UK. sheena.derry@ndcn.ox.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 11 NOV 2013



References to included reviews

  1. References to included reviews
  2. Additional references
  3. References to other published versions of this review

Additional references

  1. References to included reviews
  2. Additional references
  3. References to other published versions of this review
Attal 2010
AUREF 2012
  • PaPaS author and referee guidance. http://papas.cochrane.org/papas-documents (Accessed 23 May 2013).
Barres 2009
Beydoun 2009
Blom 1962
Bohlega 2010
Bouhassira 2008
Chaparro 2012
Chetty 2012
  • Chetty S, Baalbergen E, Bhigjee AI, Kamerman P, Ouma J, Raath R, et al. Clinical practice guidelines for management of neuropathic pain: expert panel recommendations for South Africa. South African Medical Journal 2012;102(5):312-25.
Chong 2000
Chong 2003
Chung 2010
Clauw 2013
  • Clauw DJ, Mease PJ, Palmer RH, Trugman JM, Wang Y. Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial. Arthritis Research and Therapy 2013;15(4):R88.
Derry 2012
Derry 2013
Dickenson 2007
  • Dickenson AH, Ghandehari J. Anti-convulsants and anti-depressants. Handbook of Experimenta Pharmacology 2007;177:145-77.
Dworkin 2007
Dworkin 2012
Errington 2008
Finnerup 2005
Glenny 2005
  • Glenny AM, Altman DG, Song F, Sakarovitch C, Deeks JJ, D'Amico R, et al. International Stroke Trial Collaborative Group. Indirect comparisons of competing interventions. Health Technology Assessment 2005;9(26):1-134, iii-iv.
Grahame-Smith 1992
  • Grahame-Smith DG, Aronson JK. Oxford Textbook of Clinical Pharmacology and Drug Therapy. Oxford Textbook of Clinical Pharmacology and Drug Therapy. 2nd Edition. Oxford: Oxford University Press, 1992.
Gustorff 2008
Hall 2008
Hall 2013
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Hoffman 2010
Holmes 2001
Jensen 2011
Katusic 1991
  • Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota,1945-1984. Neuroepidemiology 1991;10:276-81.
Khaliq 2007
Koopman 2009
Koroschetz 2011
Lunn 2009
McCleane 2000
McNally 2006
  • McNally JD, Matheson DA, Bakowsky VS. The epidemiology of self-reported fibromyalgia in Canada. Chronic Diseases in Canada 2006;27(1):9-16.
McQuay 1995
McQuay 2007
  • McQuay HJ, Smith LA, Moore RA. Chronic pain. In: Stevens A, Raftery J, Mant J, Simpson S editor(s). Health Care Needs Assessment. 3rd Edition. Oxford: Radcliffe Publishing, 2007. [ISBN: 978-1-84619-063-6]
McQuay 2008
Moisset 2007
Monks 1994
  • Monks R. Psychotropic drugs. In: Wall PD, Melzack R editor(s). Textbook of Pain. 3rd Edition. Edinburgh: Churchill Livingstone, 1994:963-89. [ISBN: 044304757X]
Moore 2008
  • Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15-23. [ISBN: 978-0-931092-69-5]
Moore 2010a
Moore 2010b
Moore 2010c
Moore 2012a
Moore 2012b
Moore 2013a
  • Moore RA, Derry S, Taylor RS, Straube S, Phillips CJ. The Costs and Consequences of Adequately Managed Chronic Non-Cancer Pain and Chronic Neuropathic Pain. Pain Practice 2013;March 6:Epub ahead of print. [DOI: 10.1111/papr.12050]
Moore 2013b
Moore 2013c
Moore 2013d
Moore 2013e
  • Moore RA, Cai N, Skljarevski V, Tölle TR. Duloxetine use in chronic painful conditions - individual patient data responder analysis. European Journal of Pain 2013;epub. [DOI: 10.1002/j.1532-2149.2013.00341.x]
Moulin 2007
  • Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP, Sessle BJ, et al. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Research and Management 2007;12(1):13-21.
NICE 2013
  • Draft Guidance. National Institute for Health and Clinical Excellence (2013) Neuropathic pain – pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist settings. National Institute for Health and Care Excellence Accessed August 2013. [: www.nice.org.uk/nicemedia/live/13566/64189/64189.pdf ]
Nüesch 2010
O'Connor 2009
Oaklander 2013
Perloff 2011
Phillips 2010
Rall 1992
  • Rall TW, Schleifer LS. Drugs effective in the therapy of the epilepsies. In: Goodman LS, Gilman A, Rall TW, Nies AS, Taylor P editor(s). The Pharmacological Basis of Therapeutics. 8th Edition. Toronto: McGraw-Hill, 1992:436-62.
Rappaport 1994
Semel 2010
Shea 2007
Smalldone 2004
Sommer 2012
Song 2003
Soni 2013
  • Soni A, Batra R, Gwilym S, Spector T, Hart D, Arden N, et al. Neuropathic features of joint pain: a community-based study. Arthritis and Rheumatism 2013;April 1:Epub ahead of print. [DOI: 10.1002/art.37962]
Straube 2008
Straube 2010
Sultan 2008
Sweetman 2005
  • Sweetman S (editor). Martindale: The Complete Drug Reference. 4th Edition. London: Pharmaceutical Press, 2005:353-358. [ISBN: 0 85369 550 4]
Thornton 2000
Torrance 2006
Toth 2005
Treede 2008
  • Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008;70(18):1630-5.
Wolfe 1990
Wolfe 2010
Woolf 1999
Zaccara 2011
Zheng 2010
Üçeyler 2013

References to other published versions of this review

  1. References to included reviews
  2. Additional references
  3. References to other published versions of this review
Wiffen 2000
Wiffen 2005
  • Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. 19.Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD001133.pub2]
Wiffen 2010